Background and review question Migraine is a painful and debilitating disorder that is common in children (under 12 years of age) and adolescents (12 to 17 years of age). Common symptoms reported ...

Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

If you’re in need of migraine first aid, try the following interventions. Most are free and don’t cause side effects. 1. Rest in a Dark, Quiet Room ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. The US Headache Consortium completed a landmark evidenced-based review of the literature concerning the diagnosis and treatment of migraine. [116] The ...

Expert Rev Clin Pharmacol. 2013;6(3):271-288. All FDA-approved migraine treatments are approved only for adults. No migraine products have officially been approved for use in children. Other types ...

Shades for Migraine aims to make migraine and its impact more visible. Sunglasses — symbolizing light sensitivity, a common symptom — also serve as a powerful symbol of support.

MINNEAPOLIS — Treatment of migraine with remote electrical neuromodulation was safe and efficacious, and it did not require a significant dose increase with consistent use over a period of 3 ...

Researchers at the Headache Center of the University of Naples "Federico II" gave the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide to 26 adults with obesity and chronic migraine ...